Table 9. Treatment Options for Women With Axillary Node-Positive Breast
Cancer
| Patient Group | Treatments |
| Premenopausal, ER-positive or PR-positive | Chemotherapy plus tamoxifen, chemotherapy plus ovarian ablation/GnRH analog, chemotherapy plus tamoxifen plus ovarian ablation/GnRH analoga, ovarian ablation alone or with tamoxifen or GnRH alone or with tamoxifen |
| Premenopausal, ER-negative or PR-negative | Chemotherapy |
| Postmenopausal, ER-positive or PR-positive | Upfront AI or tamoxifen followed by AI plus chemotherapy, upfront AI or tamoxifen followed by AI alone |
| Postmenopausal, ER-negative or PR-negative | Chemotherapy |
| AI= aromatase inhibitors; ER = estrogen receptor; GnRH = gonadotropin-releasing hormone; PR = progesterone receptor |
| a Note: This treatment option is under clinical evaluation. |
